ACM
Aquatic Capital Management Portfolio holdings
AUM
$4.95B
1-Year Return
14.13%
This Quarter Return
+4.73%
1 Year Return
+14.13%
3 Year Return
+25.42%
5 Year Return
–
10 Year Return
–
AUM
$3.82B
AUM Growth
+$1.11B
(+41%)
Cap. Flow
+$1.03B
Cap. Flow
% of AUM
27.02%
Top 10 Holdings %
Top 10 Hldgs %
13.12%
Holding
1,618
New
454
Increased
419
Reduced
228
Closed
515
Top Buys
| 1 |
Microsoft
MSFT
|
+$72.8M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$57.5M |
| 3 |
Eli Lilly
LLY
|
+$45.6M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$42.5M |
| 5 |
Chevron
CVX
|
+$37.3M |
Top Sells
| 1 |
PepsiCo
PEP
|
+$47.2M |
| 2 |
CME Group
CME
|
+$41.3M |
| 3 |
Northrop Grumman
NOC
|
+$38.9M |
| 4 |
Exxon Mobil
XOM
|
+$35.9M |
| 5 |
Apple
AAPL
|
+$35.3M |
Sector Composition
| 1 | Technology | 24.08% |
| 2 | Consumer Discretionary | 16.83% |
| 3 | Healthcare | 11.88% |
| 4 | Financials | 11.76% |
| 5 | Industrials | 11.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
926
Miller Industries
MLR
$469M
| $97.6K | ﹤0.01% |
1,600
+400
| +33% | +$24.4K |
|
927
Olympic Steel
ZEUS
$371M
| $97.5K | ﹤0.01% |
+2,500
| New | +$97.5K |
|
928
Ziff Davis
ZD
$1.55B
| $97.3K | ﹤0.01% |
+2,000
| New | +$97.3K |
|
929
UMB Financial
UMBF
$9.24B
| $94.6K | ﹤0.01% |
900
-3,900
| -81% | -$410K |
|
930
Merchants Bancorp
MBIN
$1.46B
| $94.4K | ﹤0.01% |
2,100
-2,300
| -52% | -$103K |
|
931
US Physical Therapy
USPH
$1.25B
| $93.1K | ﹤0.01% |
1,100
-1,500
| -58% | -$127K |
|
932
Alpha and Omega Semiconductor
AOSL
$873M
| $92.8K | ﹤0.01% |
+2,500
| New | +$92.8K |
|
933
SI-BONE Inc
SIBN
$695M
| $92.3K | ﹤0.01% |
6,600
-12,000
| -65% | -$168K |
|
934
Ducommun
DCO
$1.4B
| $92.2K | ﹤0.01% |
1,400
-200
| -13% | -$13.2K |
|
935
Akero Therapeutics
AKRO
$3.59B
| $91.8K | ﹤0.01% |
+3,200
| New | +$91.8K |
|
936
Ligand Pharmaceuticals
LGND
$3.29B
| $90.1K | ﹤0.01% |
900
-900
| -50% | -$90.1K |
|
937
Helix Energy Solutions
HLX
$927M
| $88.8K | ﹤0.01% |
8,000
-35,800
| -82% | -$397K |
|
|
BCPC
938
Balchem Corporation
BCPC
$5.15B
| $88K | ﹤0.01% |
+500
| New | +$88K |
|
939
Supernus Pharmaceuticals
SUPN
$2.6B
| $87.3K | ﹤0.01% |
+2,800
| New | +$87.3K |
|
940
Sabre
SABR
$730M
| $86.6K | ﹤0.01% |
+23,600
| New | +$86.6K |
|
941
Scansource
SCSC
$978M
| $86.5K | ﹤0.01% |
1,800
-300
| -14% | -$14.4K |
|
942
Xometry
XMTR
$2.52B
| $86.3K | ﹤0.01% |
+4,700
| New | +$86.3K |
|
943
Guess, Inc.
GES
$871M
| $85.7K | ﹤0.01% |
+4,259
| New | +$85.7K |
|
944
The Honest Company
HNST
$441M
| $85.3K | ﹤0.01% |
23,900
+22,500
| +1,607% | +$80.3K |
|
945
RCI Hospitality Holdings
RICK
$303M
| $84.6K | ﹤0.01% |
1,900
-2,700
| -59% | -$120K |
|
946
Old Second Bancorp
OSBC
$960M
| $84.2K | ﹤0.01% |
+5,400
| New | +$84.2K |
|
947
Marcus & Millichap
MMI
$1.28B
| $83.2K | ﹤0.01% |
2,100
-1,500
| -42% | -$59.4K |
|
948
Genesco
GCO
$361M
| $81.5K | ﹤0.01% |
3,000
-1,700
| -36% | -$46.2K |
|
949
Consensus Cloud Solutions
CCSI
$537M
| $77.7K | ﹤0.01% |
+3,300
| New | +$77.7K |
|
950
Arcturus Therapeutics
ARCT
$483M
| $76.6K | ﹤0.01% |
3,300
-27,700
| -89% | -$643K |
|